Wesley Brundridge, DO
Ophthalmic Plastic and Reconstructive Surgery · Fort Sam Houston, TXNPI 1073932786
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,104 of the $7,384 with a category attached, or 69.1%. 14 manufacturers reported payments, led by Biotissue Holdings Inc. at 44.9% of the total.
Across 111 payments — averaging $66.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$3K
- Amgen$2K
- Alcon$366
- Medical Device Business Services, Inc.$300
- Stryker$250
- Bausch & Lomb Americas Inc.$145
- plus $639 from 8 others
What the payments were for
- Travel & lodging$1,88426%
- Food & beverage$5,10469%
- Education$3965%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 18 | $3,316 |
| Amgen(2 entities) | 76 | $2,369 |
| Alcon | 3 | $366 |
| Medical Device Business Services, Inc. | 1 | $300 |
| Stryker | 2 | $250 |
| Bausch & Lomb Americas Inc. | 1 | $145 |
| Dompe US, Inc. | 1 | $122 |
| Ocular Therapeutix, Inc. | 1 | $107 |
| Nova Eye, Inc. | 1 | $105 |
| Rxsight Inc | 1 | $101 |
| ANI Pharmaceuticals, Inc. | 1 | $86 |
| AbbVie(2 entities) | 3 | $65 |
| Staar Surgical Company | 1 | $34 |
| Merz North America, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$1,265
- VYZULTA$289
- Prokera$263
- AmnioGraft$263
- NA$160
- MIEBO$145
- XIIDRA$145
- Centurion$134
- Clareon$129
- Oxervate$122
- DEXTENZA$107
- Hydrus Microstent$103
- RXSIGHT CONTACT LENS$101
- RXSIGHT INJECTOR CARTRIDGE$101
- RXSIGHT INJECTOR HANDPIECE$101
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$101
- LIGHT ADJUSTABLE LENS (LAL)$101
How this compares
$7,384 in reported general payments places this provider in the 85th percentile of 36 ophthalmic plastic and reconstructive surgery providers in Texas.
See all ophthalmic plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 114 | $1,274 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 41 | $414 |
| Mupirocin | 14 | $135 |
| Methylprednisolone | 11 | $93 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $45 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Fort Sam Houston
- Vikram DurairajAustin$379K
- David GayDripping Springs$93K
- Richard AllenAustin$32K
- Timothy McCulleyHouston$12K
- Tanya KhanAustin$10K
- David HolckSan Antonio$7K
- Brian WongGalveston$5K
- Irina BelinskyAustin$5K
- Brett DaviesJbsa Lackland$5K
- Margaret PfeifferDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.